We have been selected for the 2017 entrepreneur awards of Ernst & Young…
June, 2024. During its participation in ASCO, XENOTHERA….
April, 2024. The AACR Annual Meeting in San Diego was a pivotal...
March, 2024. FIPO is the first-in-human trial of XON7, the first anti-solid...